Signal Bay Appoints New CFO and Uplists to the OTCQB Venture Marketplace

November 15, 2016

Nov 14, 2016, SGBY OTC Disclosure & News Service Bend, Oregon, Nov. 14, 2016 (GLOBE NEWSWIRE) Signal Bay, Inc. (OTCQB: SGBY) a Life Science company and the market leader in cannabis testing and laboratory services is pleased to announce that the Company has been uplisted and approved for trading on the OTCQB Marketplace for early stage and developing U.S. and international companies. The company has also engaged and appointed Christian Carnell, CPA as Chief Financial Officer (CFO). With


Skyline Medical Appoints J. Melville Engle and Timothy A. Krochuk to its Board of Directors

October 27, 2016

MINNEAPOLIS, Oct. 27, 2016, SKLN, (GLOBE NEWSWIRE) Skyline Medical Inc. (NASDAQ:SKLN) (“Skyline” or “the Company”), producer of the FDA-approved STREAMWAY® System for automated, direct-to-drain medical fluid disposal, announces the appointments of Timothy A. Krochuk and J. Melville (“Mel”) Engle to its Board of Directors, effective as of today. These appointments increase the number of Directors to five, all of whom are independent directors. “We are delighted to welcome such talented and experienced professionals as Tim and Mel to the

GreenVision Systems a StereoVision Subsidiary Appoints Walter Marrero Melendez Esq. Chief Operating Officer and Board of Directors Member With Immediate Effect

October 10, 2016

LAS VEGAS, NV SVSN, (Marketwired Oct 10, 2016) StereoVision Entertainment Inc. (OTC PINK: SVSN), a publicly traded Nevada company announced today that their jointly owned Puerto Rico subsidiary GreenVision Systems has named Walter Marrero Melendez Esq. Chief Operating Officer and Board of Directors member with immediate effect. Mr. Marrero is an experienced litigator and seasoned full-service governmental, international business and lobbying practitioner. With more than 25 years of legal and practical entrepreneurial business experience, he regularly counsels clients regarding

PharmaCyte Biotech Appoints Former Johnson & Johnson Executive as Senior Business Development Advisor

May 3, 2016

SILVER SPRING, Md., May 03, 2016, PMCB, (GLOBE NEWSWIRE) PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box®, today announced that it has appointed Dr. Sanjay Batra as its Senior Business Development Advisor. Dr. Sanjay Batra brings to PharmaCyte more than 20 years of global healthcare and entrepreneurial experience in start-ups, biotech and large pharma. Dr. Batra spent 10 years at Johnson & The post PharmaCyte Biotech Appoints Former Johnson & Johnson Executive as Senior Business Development Advisor appeared first on Public Wire.

eXp Realty International Corporation Appoints COO and CFO

March 22, 2016

BELLINGHAM, WA / March 21, 2016 / eXp Realty International Corporation (OTCQB: EXPI), announced today that it has appointed Peter Nobel as its new Chief Operating Officer and Alan Goldman as its new Chief Financial Officer, effective March 16, 2016. Dr. Nobel joins the Company after nearly 20 years as a Program Manager for Microsoft Corporation where he managed teams of program managers, developers, data analysts, and user researchers in designing and creating analysis and reporting tools, and dashboards to track metrics and performance. Nobel also employed Scrum for User Research to gain customer insight and analyzed data sets to provide strategic direction in the areas of competitive mobile devices, education devices, and the levers of Net Promoter Score (NPS). Nobel also designed and managed the agile development of numerous applications to help understand basic usage and problems customers were encountering; and, created a qualitative feedback tool, Send-a-Smile, that is used tod

Immune Therapeutics, Inc., Appoints Two New Board Members

March 3, 2016

ORLANDO, Fla., March 3, 2016, IMUN, /PRNewswire/  Immune Therapeutics, Inc. (OTC:BB IMUN), a specialty pharmaceutical company involved in the manufacture, commercialization, distribution and marketing of novel, patented therapies to combat chronic, life-threatening diseases through the activation and modulation of the body s immune system, today announced the appointment of two new members to its Board of Directors: Clifford A. Selsky, Ph.D., MD, and Paul Akin. Paul Akin and Dr. Selsky s breadth of knowledge and experience will provide invaluable insight to Immune as we continue to grow the business and strive to deliver innovative therapies in emerging nations, said Noreen Griffin, CEO. I m pleased to welcome both Paul Akin and Dr. Clifford Selsky to the board. Paul brings an extraordinary depth of financial experience developed across his operating and board roles, while Dr. Selsky brings critical perspective as a scientist, physician and patient advocate, said Chris Pearce COO. Pa

Marijuana Company of America Appoints Dr. Gerry Bedore and Robert Calkin to Advisory Board

February 22, 2016

BONSALL, CA MCOA, (Marketwired) 02/22/16 MARIJUANA COMPANY OF AMERICA ( MCOA or the Company ) (OTC PINK: MCOA), an innovative cannabis marketing and distribution company, is pleased to announced that it has appointed Dr. Gerry Bedore and Mr. Robert Calkin as strategic advisors. MCOA continues to recruit subject matter experts as strategic advisors with specific expertise in cannabis regulation, cultivation, processing, manufacturing, product development, marketing, brand development and recognition, distribution and logistics, science, nutrition, marketing, distribution, legal, compliance and many other areas critical to the success of the Company. Dr. Gerry Bedore has 18 years Mid Management, Sr. Management and Executive experience in building and scaling of technology enhanced and technology based learning programs from the ground up. Gerry is widely recognized for his work in building and supporting many of the most successful online education organizations in the world today. Gerr